- Home
- IMNM vs TRMD Comparison
IMNM vs TRMD Comparison
Compare IMNM & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | TRMD |
|---|---|---|
| Founded | 2006 | 1889 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | IMNM | TRMD |
|---|---|---|
| Price | $24.61 | $30.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 1 |
| Target Price | $32.80 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 1.2M | 729.6K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 7.12% |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,941,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,127.34 | N/A |
| P/E Ratio | ★ N/A | $9.61 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.15 | $15.35 |
| 52 Week High | $27.65 | $31.76 |
Technical Indicators
Market Signals| Indicator | IMNM | TRMD |
|---|---|---|
| Relative Strength Index (RSI) | 66.42 | 61.27 |
| Support Level | $23.67 | $21.54 |
| Resistance Level | $25.30 | $31.76 |
| Average True Range (ATR) | 1.13 | 0.97 |
| MACD | 0.36 | 0.10 |
| Stochastic Oscillator | 94.87 | 83.61 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About TRMD TORM plc
TORM plc operates as a shipping company mainly owning and operating a fleet of product tankers. It is engaged in the transportation of refined oil products and clean petroleum products, including gasoline, jet fuel, naphtha and diesel oil. The Company operates through two segments: the Tanker segment and the Marine Engineering segment, deriving the majority of its revenue from the Tanker segment.